- Home
- IDN vs BRNS Comparison
IDN vs BRNS Comparison
Compare IDN & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDN
- BRNS
- Stock Information
- Founded
- IDN 1994
- BRNS 2016
- Country
- IDN United States
- BRNS United Kingdom
- Employees
- IDN N/A
- BRNS N/A
- Industry
- IDN Computer Software: Prepackaged Software
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- IDN Technology
- BRNS Health Care
- Exchange
- IDN Nasdaq
- BRNS Nasdaq
- Market Cap
- IDN 50.8M
- BRNS 43.8M
- IPO Year
- IDN 1999
- BRNS 2021
- Fundamental
- Price
- IDN $2.65
- BRNS $1.00
- Analyst Decision
- IDN Buy
- BRNS Strong Buy
- Analyst Count
- IDN 3
- BRNS 2
- Target Price
- IDN $3.33
- BRNS $3.00
- AVG Volume (30 Days)
- IDN 59.1K
- BRNS 43.4K
- Earning Date
- IDN 03-20-2025
- BRNS 03-19-2025
- Dividend Yield
- IDN N/A
- BRNS N/A
- EPS Growth
- IDN N/A
- BRNS N/A
- EPS
- IDN N/A
- BRNS N/A
- Revenue
- IDN $19,236,000.00
- BRNS $14,969,000.00
- Revenue This Year
- IDN $2.09
- BRNS $1,803.87
- Revenue Next Year
- IDN $8.67
- BRNS N/A
- P/E Ratio
- IDN N/A
- BRNS N/A
- Revenue Growth
- IDN 5.22
- BRNS 106.21
- 52 Week Low
- IDN $1.67
- BRNS $0.80
- 52 Week High
- IDN $4.46
- BRNS $4.16
- Technical
- Relative Strength Index (RSI)
- IDN 48.32
- BRNS 46.05
- Support Level
- IDN $2.51
- BRNS $0.96
- Resistance Level
- IDN $2.70
- BRNS $1.15
- Average True Range (ATR)
- IDN 0.16
- BRNS 0.12
- MACD
- IDN -0.01
- BRNS 0.00
- Stochastic Oscillator
- IDN 36.84
- BRNS 16.67
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The company makes it possible for its clients to increase revenues, improve customer service, and increase operational efficiencies. Under the new direction, the company is focused on partnering with banks credit card issuers, and retailers to prevent fraud. It derives revenue through Sales of systems, subscription fees, Sale of software upgrades, and extended maintenance programs.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.